ReviewAnnals of neurosciences2025
Assessing the Impact of BMI and Glycaemic Control on Cardiac Autonomic Neuropathy in Patients with Early and Long-standing Diabetes Mellitus: A Window of Opportunity.
Review in Annals of neurosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cardiac autonomic neuropathy (CAN) is a well-known, yet underreported, complication of Diabetes mellitus (DM). CAN assessment can be performed using heart rate variability (HRV) and Ewing's battery of tests. Severity of CAN may be affected by multiple factors like glycaemic control, obesity and co-existing distal neuropathy. However, the relationship between CAN and these factors remains underexplored. Purpose: We conducted the present study to assess the relationship between the prevalence of CAN in patients with DM and associated factors like obesity and glycaemic control. Methods: Clinically diagnosed patients of DM were recruited. They were divided into duration <5 years (early onset, 'Dur < 5') and ≥5 years (long-standing, 'Dur ≥ 5') and evaluated using HRV and Ewing's battery of tests. Apparently, healthy young adult controls were recruited as controls. Cardiac autonomic tone and reactivity parameters were compared between the groups. Results: We recruited 50 patients with DM (25 'Dur < 5' and 25 'Dur ≥ 5') and 34 healthy controls. Controls were significantly younger than the patients. Height, weight and BMI were comparable between the groups. Patients had impaired cardiac autonomic tone but preserved response to reactivity tests when compared with controls. Normal BMI and good glycaemic control, indicated by lower values of HbA1C, may be responsible for these results. Conclusions: Patients with DM demonstrated reduced tone but preserved autonomic reactivity, even when compared with younger, apparently healthy controls. Normal BMI and relatively lower HbA1C values may contribute to this phenomenon. Such patients may be identified and targeted for early clinical intervention for ANS salvage.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.